Study of the interaction between fisetin and human serum albumin: A biophysical approach

Protein and Peptide Letters

Volumn 19, Issue 6, 2012, Pages 604-615

  Roy, Atanu Singha ^a   Dinda, Amit Kumar ^a   Dasgupta, Swagata ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Binding; Docking; Fisetin; Fluorescence and human serum albumin

Indexed keywords

FISETIN; HUMAN SERUM ALBUMIN; IBUPROFEN; POTASSIUM CHLORIDE; WARFARIN;

ALPHA HELIX; ANISOTROPY; ARTICLE; BINDING AFFINITY; BIOPHYSICS; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG PROTEIN BINDING; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MOLECULAR DOCKING; PH; PROTEIN DOMAIN; STATIC ELECTRICITY; ULTRAVIOLET SPECTROSCOPY;

EID: 84861954679     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986612800493995     Document Type: Article

References (59)

1. Gorman, D.; Sytnik, A.; Kasha, M. Spectroscopy of amplified spontaneous emission laser spikes in polyhydroxyflavones. J. Phys. Chem. A, 1997, 101, 672-677. (Pubitemid 127591217)
2. Pathenopoulos, D.A.; Kasha, M. Coherent pulse and environmental characteristics of the intramolecular proton-transfer lasers based on 3-hydroxyflavone and fisetin. Chem. Phys. Lett., 1988, 146, 77-85.
3. Takahama, U. Suppression of lipid photoperox-idation by quercetin and its glycosides in spinach chloro-plasts. Photochem. Photobiol., 1983, 38, 363-367.
4. Jovanovic, S.V.; Steenken, S.; Tosic, M.; Marjanovic, B.; Simic, M. G. Flavonoids as antioxidants. J. Am. Chem. Soc., 1994, 116, 4846-4851. (Pubitemid 24255827)
5. Ozgov, .; Hemnek, J.; Gut, I. Different antioxidant effects of polyphenols on lipid peroxidation and hydroxyl radicals in the NADPH-, Fe-ascorbate-and Fe-microsomal systems. Biochem. Pharmacol., 2003, 66, 1127-1137. (Pubitemid 37130288)
6. van Acker, F.A.A.; Schouten, O.; Haenen, G.R.M.M.; van der Vijgh, W.J.F.; Bast, A. Flavonoids can replace -tocopherol as an antioxidant. FEBS Lett., 2000, 473, 145-148. (Pubitemid 30254278)
7. Fotsis, T.; Pepper, M.S.; Montesano, R.; Aktas, E.; Breit, S.; Schweigerer, L.; Rasku, S.; Wähälä, K.; Adlercreutz, H. Phytoestrogens and inhibition of angiogenesis. Baillieres Clin. Endocrinol. Metab., 1998, 12, 649-666. (Pubitemid 29261276)
8. Stopper, H.; Schmitt, E.; Kobras, K. Genotoxicity of phytoestrogens. Mutat. Res., 2005, 574, 139-155. (Pubitemid 40725975)
9. Park, H.H.; Lee, S.; Oh, J.M.; Lee, M.S.; Yoon, K.H.; Park, B.H.; Kim, J.W.; Song, H.; Kim, S.H. Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol. Res., 2007, 55, 31-37. (Pubitemid 46108584)
10. Hirano, T.; Higa, S.; Arimitsu, J.; Naka, T.; Shima, Y.; Ohshima, S.; Fujimoto, M.; Yamadori, T.; Kawase, I.; Tanaka, T. Flavonoids such as Luteolin, Fisetin and Apigenin Are Inhibitors of Interleukin-4 and Interleukin-13 Production by ActivatedHuman Basophils. Int. Arch. Allergy Immuno., 2004, 134, 135-140. (Pubitemid 38716259)
11. Cheong, H.; Ryu, S.Y.; Oak, M.H.; Cheon, S. H.; Yoo, G.S.; Kim, K.M. Studies of structural activity relationships of flavonoids for the anti-allergic actions. Arch. Pharm. Res., 1998, 21, 478-480. (Pubitemid 128661839)
12. Ferreira, A.C.F.; Lisboa, P.C.; Oliveira, K.J.; Lima, L.P.; Barros, I.A.; Carvalho, D.P. Inhibition of thyroid type-1 deiodinase activity by flavonoids. Food Chem. Toxicol., 2002, 40, 913-917. (Pubitemid 34626698)
13. Wang, H.K.; Xia, Y.; Yang, Z.Y.; Natschke, S.L.; Lee, K.H. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv. Exp. Med. Biol., 1998, 439, 191-225. (Pubitemid 28429018)
14. Kaul, T.N.; Middleton, E., Jr.; Ogra, P.L. Antiviral effect of flavonoids on human viruses. J. Med. Virol., 1985, 15, 71-79. (Pubitemid 15184364)
15. Park, J.B. Flavonoids are potential inhibitors of glucose uptake in U937 cells. Biochem. Biophys. Res. Commun., 1999, 260, 568-574. (Pubitemid 29352102)
16. Kragh-Hansen, U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev., 1981, 33, 17-53.
17. Peters, T. Jr. Serum albumin. Adv. Protein Chem., 1985, 37, 161-245.
18. He, X.M.; Carter, D.C. Atomic structure and chemistry of human serum albumin. Nature, 1992, 358, 209-215.
19. Bertucci, C.; Domenici, E. Reversible and Covalent Binding of Drugs to Human Serum Albumin: Methodological Approaches and Physiological Relevance. Curr. Med. Chem., 2002, 9, 1463-1481. (Pubitemid 34823027)
20. Rang, H.P.; Dale, M.M.; Ritter, J.M.; Moore, P. Pharmacology, 5th ed.; Churchill Livingstone: New York, 2003.
21. Gonzalez-Jimenez J.; Frutos, G.; Cayre, I.; Cortijo, M. Chlorpheniramine binding to human serum albumin by fluorescence quenching measurements. Biochimie, 1991, 73, 551-556.
22. Perry, J.L.; Goldsmith, M.R.; Williams, T.R.; Radack, K.P.; Christensen, T.; Gorham, J.; Pasquinelli, M.A.; Toone, E.J.; Beratan, D. N.; Simon, J. D. Binding of Warfarin Influences the Acid-Base Equilibrium of H242 in Sudlow Site I of Human Serum Albumin. Photochem. Photobiol., 2006, 82, 1365-1369. (Pubitemid 44702021)
23. Tang J. H.; Luan F.; Chen, X.G. Binding analysis of glycyrrhetinic acid to human serum albumin: fluorescence spectroscopy, FTIR and molecular modeling. Bioorg. Med. Chem., 2006, 14, 3210-3217.
24. Whitmore, L.; Wallace, B.A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res., 2004, 32, W668-W673. (Pubitemid 38997420)
25. Byler, S.; Susi, H. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers, 1986, 25, 469-487.
26. Berman, M.; Westbrook, J.; Feng, Z. Gililand, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The protein data bank. Nucleic Acids Res., 2000, 28, 235-242. (Pubitemid 30047768)
27. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A Fast Flexible Docking Method using an Incremental Construction Algorithm. J. Mol. Biol., 1996, 261, 470-489. (Pubitemid 26335901)
28. The PyMoL molecular graphics system. San Carlos, (CA): DeLano Scientific: 2004. http://www.pymol.sourceforge.net.
29. Hubbard, S.J.; Thornton, J.M. 'NACCESS.' Computer program. Department of Biochemistry and Molecular Biology, University College of London: 1993.
30. Foster, J.F. Albumin Structure, Function and Uses. Rosenoer V. M.; Oratz M.; Rothschild M.A. eds.; Pergamon Press: New York, 1977.
31. Peters, T. Jr. The Plasma Proteins. Putnam, F.W. ed.; Academic Press: London, 1975.
32. Fink, A.L.; Calciano, L.J.; Goto, Y.; Kurotsu, T.; Palleros, D.R. Classification of acid denaturation of proteins: intermediates and unfolded states. Biochemistry, 1994, 33, 12504-12511. (Pubitemid 24340457)
33. Muzammil, S.; Kumar, Y.; Tayyab, S. Molten globule-like state of human serum albumin at low pH. Eur. J. Biochem., 1999, 266, 26-32.
34. Peters, T., Jr. All About Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press; Inc.: New York, 1996.
35. Bos, O.J.; Labro, J.F.; Fischer, M.J.; Wilting, J.; Janssen, L.H. The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin. J. Biol. Chem., 1989, 264, 953-959. (Pubitemid 19038078)
36. Qin, C.; Xie, M-X.; Liu, Y. Characterization of the myricetinhuman serum albumin complex by spectroscopic and molecular modeling approaches. Biomacromolecules, 2007, 8, 2182-2189. (Pubitemid 47104304)
37. Mabry, T.J.; Markham, K.R.; Thomas, M.B. The systematic identification of flavonoids. Springer-Verlag: New York, 1970.
38. Dufour, C.; Dangles, O. Flovonoid-serum albumin complexation: determination of binding constants binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta, 2005, 1721, 164-173. (Pubitemid 40093524)
39. Zsila, F.; Bikádi, Z.; Simonyi, M. Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods. Biochem. Pharmacol., 2003, 65, 447-456. (Pubitemid 36084562)
40. Benesi, H.A.; Hildebrand, J.H. Spectrophotometric investigation of iodine with aromatic hydrocarbons. J. Am. Chem. Soc., 1949, 71, 2703-2707.
41. Xie, M.X.; Long, M.; Liu, Y.; Qin, C.; Wang, Y.D. Characterization of the interaction between human serum albumin and morin. Biochim. Biophys. Acta, 2006, 1760, 1184-1191. (Pubitemid 43928259)
42. Lakowicz, J.R. Principles of Fluorescence Spectroscopy, 2nd ed.; Kluwer Academic/Plenum Publishers: New York, 1999.
43. Gelamo, E.L.; Silva, C.H.T.P.; Imasato, H.; Tabak, M. Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: spectroscopy and modelling. Biochim. Biophys. Acta, 2002, 1594, 84-99. (Pubitemid 34131728)
44. Chen, G.Z.; Huang, X.Z.; Xu, J.G.; Zheng, Z.Z.; Wang, Z.B. The Methods of Fluorescence Analysis, 2nd ed.; Beijing Science Press: 1990.
45. Sengupta, B.; Banerjee, A; Sengupta, P.K. Interactions of the the plant flavonoid fisetin with macromolecular targets: insights from fluorescence spectroscopic studies. J. Photochem. Photobiol. B, 2005, 80, 79-86. (Pubitemid 40984405)
46. Hu, Y.J.; Liu, Y.; Wang, J.B.; Xiao, X.H.; Qu, S.S. Study of the interaction between monoammonium gly-cyrrhizinate and bovine serum albumin. J. Pharm. Biomed. Anal., 2004, 36, 915-919. (Pubitemid 39469437)
47. Ross, P.D.; Subramanian, S. hermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, 1981, 20, 3096-3102.
48. Sudlow, G.; Birkett, D.J.; Wade, D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol., 1975, 11, 824-832.
49. Sudlow, G.; Birkett, D.J.; Wade, D.N. Further characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol., 1976, 12, 1052-1061.
50. Bentley, K.L.; Thompson, L.K.; Klebe, R.J.; Horowitz, P.M. Fluorescence polarization: A general method for measuring ligand binding and membrane microviscosity. BioTechniques, 1985, 3, 356-366.
51. Sengupta, B.; Sengupta, P.K. The interaction of quercetin with human serum albumin: A fluorescence spectroscopic study. Biochem. Biophys. Res. Commun., 2002, 299, 400-403. (Pubitemid 35365642)
52. Qi, Z.; Zhang, Y.; Liao, F.; Yang, Y.; Liu, Y.; Yang, X. Probing the binding of morin to human serum albumin by optical spectroscopy. J. Pharma. Biomed. Anal., 2008, 46, 699-706.
53. Hong, G.; Lei, L.; Kong, Q.; Chen, X.; Hu, Z. The study on the interaction between human serum albumin and a new reagent with antitumour activity by spectrophotometric methods. J. Photochem. Photobiol. A, 2004, 167, 213-221.
54. Vanderkooi, J.M.; Ierokomas, A.; Nakmura, H.; Martonosi, A. Fluorescence energy transfer between Ca+2 transport ATPase molecule in artificial membranes. Biochemistry, 1977, 16, 1262-1267. (Pubitemid 8083089)
55. Mohammadi, F.; Bordbar, A.K.; Divasalar, A.; Mohammadi, K.; Saboury, A.A. Analysis of binding interaction of curcumin and diacetylcurcumin with human and bovine serum albumin using fluorescence and circular dichroism spectroscopy. Protein J., 2009, 28, 189-196.
56. Elliott, A.; Ambrose, E.J. Structure of synthetic polypeptides. Nature, 1950, 165, 921-922.
57. Krimm, S.; Bandekar, J. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv. Protein Chem., 1986, 38, 181-364.
58. Bourassa, P.; Kanakis, C.D.; Tarantilis, P.; Pollissiou, M.G.; Tajmir-Riahi, H.A. Resveratrol, genistein and curcumin bind human serum albumin. J. Phys. Chem. B, 2010, 114, 3348-3354.
59. Sytnik, A.; Lritvinyuk, I. Energy Transfer to a Proton-Transfer Fluorescence Probe: Tryptophan to a Flavonol in Human Serum Albumin. Proc. Natl. Acad. Sci. USA, 1996, 93, 12959-12963. (Pubitemid 26382751)